Treatment of coexisting diabetes and hypertension

Norman M Kaplan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The rapidly growing number of patients with coexisting diabetes and hypertension must be intensively treated to protect them from their very high risk for premature cardiovascular morbidity and mortality. After careful ascertainment of their out-of-the-office blood pressure, and testing for postural hypotension, therapy should consist of both lifestyle modifications and antihypertensive drugs. Usually, two or more such drugs are needed to bring blood pressure below the 130/85 mm Hg level. In addition, control of hyperglycemia and dyslipidemia is usually required. Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension.

Original languageEnglish (US)
Pages (from-to)498-503
Number of pages6
JournalCurrent Cardiology Reports
Volume3
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Blood Pressure
Hypertension
Orthostatic Hypotension
Dyslipidemias
Hyperglycemia
Antihypertensive Agents
Life Style
Morbidity
Costs and Cost Analysis
Mortality
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of coexisting diabetes and hypertension. / Kaplan, Norman M.

In: Current Cardiology Reports, Vol. 3, No. 6, 2001, p. 498-503.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Treatment of coexisting diabetes and hypertension. In: Current Cardiology Reports. 2001 ; Vol. 3, No. 6. pp. 498-503.
@article{20cac1c2c96442ff9d141b662c8b41fa,
title = "Treatment of coexisting diabetes and hypertension",
abstract = "The rapidly growing number of patients with coexisting diabetes and hypertension must be intensively treated to protect them from their very high risk for premature cardiovascular morbidity and mortality. After careful ascertainment of their out-of-the-office blood pressure, and testing for postural hypotension, therapy should consist of both lifestyle modifications and antihypertensive drugs. Usually, two or more such drugs are needed to bring blood pressure below the 130/85 mm Hg level. In addition, control of hyperglycemia and dyslipidemia is usually required. Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension.",
author = "Kaplan, {Norman M}",
year = "2001",
doi = "10.1007/s11886-001-0072-3",
language = "English (US)",
volume = "3",
pages = "498--503",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Treatment of coexisting diabetes and hypertension

AU - Kaplan, Norman M

PY - 2001

Y1 - 2001

N2 - The rapidly growing number of patients with coexisting diabetes and hypertension must be intensively treated to protect them from their very high risk for premature cardiovascular morbidity and mortality. After careful ascertainment of their out-of-the-office blood pressure, and testing for postural hypotension, therapy should consist of both lifestyle modifications and antihypertensive drugs. Usually, two or more such drugs are needed to bring blood pressure below the 130/85 mm Hg level. In addition, control of hyperglycemia and dyslipidemia is usually required. Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension.

AB - The rapidly growing number of patients with coexisting diabetes and hypertension must be intensively treated to protect them from their very high risk for premature cardiovascular morbidity and mortality. After careful ascertainment of their out-of-the-office blood pressure, and testing for postural hypotension, therapy should consist of both lifestyle modifications and antihypertensive drugs. Usually, two or more such drugs are needed to bring blood pressure below the 130/85 mm Hg level. In addition, control of hyperglycemia and dyslipidemia is usually required. Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0035515356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035515356&partnerID=8YFLogxK

U2 - 10.1007/s11886-001-0072-3

DO - 10.1007/s11886-001-0072-3

M3 - Article

C2 - 11602081

AN - SCOPUS:0035515356

VL - 3

SP - 498

EP - 503

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 6

ER -